Boehringer Ingelheim and Enara bio companies are going to search and develop new revolutionary ways to fight cancer.
Myovant Sciences has approved its first product, Orgovyx, for the treatment of advanced prostate cancer.
The FDA has announced the breakthrough therapy status of the combination of two Roche antibodies
The American regulator has granted the status of an orphan-drug to the experimental drug AZP-3601 manufactured by Amolyt Pharma.
Scientists have introduced a new class of drugs for treating PMS symptoms.
The effect of taking certain antioxidants on the risk of developing Parkinson's disease has been studied.
Scientists from the University of Montana have developed a thermostable gel for ear drops.
Rani Therapeutics has long been working on a robotic tablet designed to replace drug injections requiring frequent administration.
For the first time scientists have successfully used CRISPR-Cas9 genome editing technology to treat malignant tumors.
Scientists from America have managed to develop a promising compound - T405, which can destroy an extremely dangerous pathogen Mycobacterium abscessus, which is resistant to existing antibiotics.